Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)

Amadori, Sergio; Suciu, Stefan; Stasi, Roberto; Salih, Helmut R.; Selleslag, Dominik; Muus, Petra; De Fabritiis, Paolo; Venditti, Adriano; Ho, Anthony D.; Luebbert, Michael; Thomas, Xavier; Latagliata, Roberto; Halkes, Constantijn J. M.; Falzetti, Franca; Magro, Domenico; Guimaraes, Jose E.; Berneman, Zwi; Specchia, Giorgina; Karrasch, Matthias; Fazi, Paola; Vignetti, Marco; Willemze, Roel; de Witte, Theo; Marie, Jean-Pierre

Sequential Combination of Gemtuzumab Ozogamicin and Standard Chemotherapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia: Results of a Randomized Phase III Trial by the EORTC and GIMEMA Consortium (AML-17)

Autor(en):

Amadori, Sergio; Suciu, Stefan; Stasi, Roberto; Salih, Helmut R.; Selleslag, Dominik; Muus, Petra; De Fabritiis, Paolo; Venditti, Adriano; Ho, Anthony D.; Luebbert, Michael; Thomas, Xavier; Latagliata, Roberto; Halkes, Constantijn J. M.; Falzetti, Franca; Magro, Domenico; Guimaraes, Jose E.; Berneman, Zwi; Specchia, Giorgina; Karrasch, Matthias; Fazi, Paola; Vignetti, Marco; Willemze, Roel; de Witte, Theo; Marie, Jean-Pierre

Tübinger Autor(en):

Salih, Helmut R.

Erschienen in:

Journal of Clinical Oncology (2013), Bd. 31, H. 35, S. 4424-

Verlagsangabe:

Amer Soc Clinical Oncology

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1200/JCO.2013.49.0771

ISSN:

0732-183X